Author:
Grebely Jason,Robaeys Geert,Bruggmann Philip,Aghemo Alessio,Backmund Markus,Bruneau Julie,Byrne Jude,Dalgard Olav,Feld Jordan J.,Hellard Margaret,Hickman Matthew,Kautz Achim,Litwin Alain,Lloyd Andrew R.,Mauss Stefan,Prins Maria,Swan Tracy,Schaefer Martin,Taylor Lynn E.,Dore Gregory J.
Subject
Health Policy,Medicine (miscellaneous)
Reference199 articles.
1. AASLD/IDSA (2015). Recommendations for testing, managing, and treating hepatitis C. Retrieved from www.hcvguidelines.org.
2. Assessment and treatment of hepatitis C virus infection among people who inject drugs in the opioid substitution setting: ETHOS study;Alavi;Clinical Infectious Diseases,2013
3. Continued low uptake of treatment for hepatitis C virus infection in a large community-based cohort of inner city residents;Alavi;Liver International,2014
4. Alavi, M., Micallef, M., Fortier, E., Dunlop, A.J., Balcomb, A.C., Day, C.A., et al. (2015, May). Effect of treatment willingness on specialist assessment and treatment uptake for hepatitis C virus infection among people who use drugs: The ETHOS study. Journal of Viral Hepatitis. http://dx.doi.org/10.1111/jvh.12415.
5. Injecting risk behaviours following treatment for hepatitis C virus infection among people who inject drugs: The Australian Trial in Acute Hepatitis C;Alavi;International Journal of Drug Policy,2015